Mayne Pharma's new battle | Ray-Ban smart glasses are all the rage | Nestlé cuts 16,000 jobs

ASX-listed Mayne Pharma saw its shares spike 14% after a court ruled that its acquirer cannot terminate its $672 million acquisition offer Ray-Ban maker EssilorLuxottica just hit record sales as smart glasses go from nerdy to need one now Nestlé’s new CEO is cutting 16,000 jobs as it looks to trim costs while also speeding up growth _ Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay   Daily newsletter: https://bit.ly/fluxnewsletter   Flux on Instagram: http://bit.ly/fluxinsta   Flux on TikTok: https://www.tiktok.com/@flux.finance   —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.__See omnystudio.com/listener for privacy information.